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while being signiﬁcant at D14 in GPR22+ (prior using mineralization
medium). From D14 to D21, Runx2 mRNA remained elevated, while
Ihh was decreased, in both controls and GPR22+. MMP13, Col10a1 and
Alp mRNA were increased, and signiﬁcantly higher in GPR22+ than in
controls. Alizarin red was still more elevated in GPR22+. These data were
consistent with the enhanced activation of ERK1/2 at D14–21 in GPR22+
compared with controls.
Conclusions: Overexpression of GPR22 blocks features from the
proliferative phase of chondrogenesis, but enhances those from the
hypertrophic and mineralization phases. This underlines a critical role for
GPR22 in the fate of chondrogenic cells, and may be of interest regarding
the hypertrophic switch of articular chondrocytes in the course of OA.
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Purpose: Proinﬂammatory cytokines, such as IL-1 and tumor necrosis
factor a (TNFa), are suspected of causing damage to osteoarthritis (OA)
cartilage. TNFa content is elevated in the synovial ﬂuid of OA joints.
There are 2 cell surface receptors for TNFa including p55 (TNFRI) and
p75 (TNFRII). TNFa and TNFRs I and II are up-regulated in OA cartilage.
For bone metabolism, mice null for TNFR1 have signiﬁcantly increased
peak bone mass, resulting from elevated bone formation. In vitro, TNFa
inhibited mineralization of osteoblasts through regulation of NF-kB
activity. Thus, whereas TNFR1 plays roles in osteoblast differentiation,
its functions in chondrocyte metabolism is unknown. Endochondral
ossiﬁcation is an essential process for development of OA, which is
characterized by cartilage degradation and osteophyte formation. The
aim of this study is to investigate the role of TNFR1 in the maintenance
of articular tissues.
Materials and Methods: Histological evaluation of aged TNFR1−/− mice:
Knee joints of TNFR1−/− and their wild-type (WT) littermates
(52–60 weeks of age) were evaluated immunohistologicaly. Whole knee
joints were removed by dissection, ﬁxed in 4% paraformaldehyde, and
decalciﬁed in EDTA. After dehydration and parafﬁn embedding, serial
5-mm sagittal sections were made from the whole medial compartment
of the knee joint. Three sections were picked up at 100-mm intervals
from the weight-bearing region of each medial plateau of tibia, and were
stained with Safranin O-fast green and HE. Osteophyte area and articular
cartilage thickness were quantiﬁed in each slide using Image-Pro Plus
4.1 software.
Surgical induction of OA in TNFR1−/− mice: TNFR1−/− and their wild-type
(WT) littermates were surgically induced to develop OA by medial
collateral ligament transection and medial meniscectomy. Four weeks
after surgery, the mice were euthanized.
Results: At 52–60 weeks of age, whereas osteophyte formation was
detected at the medio-anterior edge of tibial plateau regardless of
genotype, osteophyte area was signiﬁcantly increased in TNFR1−/−
mice. Moreover, articular cartilage thickness was reduced at medial
end region of tibia plateau in TNFR1−/− mice, suggesting ossiﬁcation
of articular chondrocyte was advanced by TNFR1 deﬁciency. We next
compared osteoarthritis development between adult littermates of
wild-type and TNFR1−/− mice by creating a surgical osteoarthritis
model through induction of instability to the knee joints. Histological
evaluation conﬁrmed that the TNFR1 deﬁciency caused signiﬁcant
acceleration for osteophyte formation. Degree of cartilage destruction
was almost comparable between TNFR1−/− and WT. Real time PCR
analysis for epiphyseal chondrocyte from new born mice revealed mRNA
expression of type X collagen, a marker for chondrocyte hypertrophy,
was signiﬁcantly elevated in TNFR1−/− mice compared to WT littermate.
Currently, we are picking up a number of candidate genes for targets of
TNFR1 in the course of chondrocyte hypertrophy using cDNA microarray
analysis.
Conclusion: Endogenous TNFR1 had a protective effect against
osteophyte formation through inhibition of type X collagen synthesis.
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Purpose: Pro-and anti-inﬂammatory factors in the synovial ﬂuid play
a role in osteoarthritis (OA), although the exact pathogenesis is still
unclear. One of these factors may be oncostatin M (OSM). OSM, a pro-
inﬂammatory cytokine of the IL-6 family. OSM has been demonstrated
to play a role in cartilage degeneration, bone turnover and synovial
inﬂammation in rheumatoid arthritis, however, its role in OA remains
unclear. The current study aimed to investigate the presence of OSM in
OA synovial ﬂuid and its role in osteoarthritic cartilage degeneration.
Methods: The OSM concentration in the synovial ﬂuid (SF) of 32 OA
patients and 24 healthy donors was determined by ELISA. The presence
of receptors for OSM in osteoarthritic and healthy cartilage explants was
determined by immunohistochemistry for the OSM- and LIF-receptor.
To study the role of OSM in OA cartilage degeneration, OA cartilage
explants of 5 donors were cultured for 14 days with and without
25% OA synovial ﬂuid of multiple OA donors, and with or without
addition of a blocking antibody against OSM. To determine if the OSM
concentrations, as present in OA SF, could exert a direct effect on cartilage
metabolism, recombinant OSM was added at these concentration.
Cartilage metabolism was determined by glycosaminoglycans (GAG)
content and release.
For statistical analysis, univariate analysis of variance was performed. To
correct for inter-donor variability a randomized block design was used.
P values <0.05 were considered signiﬁcant.
Results: The concentration of OSM in SF of osteoarthritic donors ranged
from 0–570 pg/ml (average 39 pg/ml). In healthy SFs, OSM concentration
was signiﬁcantly lower, and was only detected in one donor (ﬁgure 1;
P < 0.001). Immunohistochemistry conﬁrmed the presence of both the
LIF receptor and OSM receptor in osteoarthritic cartilage and healthy
cartilage. In healthy cartilage, only the cells in the superﬁcial layer
showed positive staining for both receptors, whereas in osteoarthritic
cartilage positive cells for both receptors were found throughout the
entire depth of the cartilage. Blocking OSM in osteoarthritic SF increased
GAG content compared to cartilage explants cultured with SF alone
(ﬁgure 1; P < 0.05). Recombinant OSM alone at a concentration of 5 or
50 pg/ml did not show an effect on cartilage metabolism. Only a high
concentration of OSM (10ng/ml) could decrease GAG content (data not
shown; P < 0.05).
Conclusions:
OSM is present at increased levels in synovial ﬂuid of osteoarthritis
patients compared to synovial ﬂuid of healthy donors. Moreover,
the expressions of receptors for OSM appeared to be increased in
osteoarthritic cartilage. Blocking OSM in the synovial ﬂuid of OA patients
increases GAG content of OA cartilage explants. OSM at concentrations
present in OA SF does not affect cartilage metabolism, suggesting that
the effect is not direct, but OSM works in concert with other factors in
the synovial ﬂuid. OSM might be a target for future therapy to inhibit
cartilage degeneration in OA.
Fig. 1. Concentration of OSM in SF (*P < 0.001). Increase of GAG content
when OSM is blocked in SF (*P < 0.05).
